- TheStreet.com•21 hours ago
Roche (RHHBY) was given emergency approval by the FDA to issue its Zika diagnostics test which can be used to screen patients who have symptoms of the disease.
- Zacks•23 hours ago
Roche Holdings (RHHBY) announced that the FDA has issued an Emergency Use Authorization (EUA) for its LightMix Zika rRT-PCR Test.
Roche Holding AG (RHHBY)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||30.86 - 31.02|
|52wk Range||29.89 - 35.13|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||22.43|
|Avg Vol (3m)||1,023,642|
|Dividend & Yield||1.02 (3.31%)|